TherapeuticsMD, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
TherapeuticsMD, Inc. has filed 1,174 SEC EDGAR filings since 16 Aug 1995

SEC filing history

Showing 251-275 of 961 matching filings.

Per page
25
Current page
11
4

4 filing

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - DONEGAN

Filing date
12 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - WALKER

Filing date
12 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - BORKOWSKI

Filing date
12 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - MILLIGAN

Filing date
12 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - FINIZIO

Filing date
12 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
19 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-00100

DEFA14A

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-00100

DEF 14A

Filing date
14 Apr 2021
Reporting date
27 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
Next action
Verify source filing
PRE 14A File 001-00100

PRE 14A

Filing date
01 Apr 2021
Reporting date
27 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
22 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - FINIZIO

Filing date
08 Mar 2021
Reporting date
04 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - MILLIGAN

Filing date
08 Mar 2021
Reporting date
04 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-253851

S-3ASR

Filing date
04 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-00100

ANNUAL REPORT

Filing date
04 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
02 Mar 2021
Reporting date
02 Mar 2021
Next action
Verify source filing
SC 13G/A File 005-32384

SC 13G/A filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
16 Feb 2021
Reporting date
11 Feb 2021
Next action
Verify source filing
424B2 File 333-226452

FORM 424(B)(2)

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-226452

424B5

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-32384

SCHEDULE 13G/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-32384

SC 13G/A filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .